Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) |
| BNF code | 0801060A0BBAAAA |
| Virtual Medicinal Product | Daunorubicin 44mg / Cytarabine 100mg powder for solution for infusion vials |
| Name | Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials |
| Abbreviated name | Vyxeos liposomal 44mg/100mg pdr for concentrate for inf |
| Date of name applicability | 17 Dec 2019 |
| Previous name | Vyxeos 44mg/100mg powder for concentrate for solution for infusion vials |
| Supplier | Jazz Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.